Anadrol

Anadrol is the trade name for oxymetholone, a 17-alpha-alkylated oral anabolic steroid with a longstanding place in androgen research. Interest in the compound centers on potent anabolic-class signaling, oral persistence, and how a heavily modified testosterone scaffold influences erythropoietic and anabolic readouts. Mechanistically, oxymetholone binds the androgen receptor and alters transcriptional programs involved in protein turnover and hematologic output, while the alkylated structure changes metabolism and hepatic burden. Research also examines the mismatch that can exist between receptor binding affinity and observed whole-system effect in certain oral steroids. Published literature and class reviews show robust anabolic-steroid signals together with prominent liver and lipid concerns typical of 17-alpha-alkylated compounds. The compound remains scientifically relevant as a potent oral androgen comparator. Research status is mature for class pharmacology and safety characterization. In this catalog, Anadrol is best described as oxymetholone, a potent oral androgen research steroid. References: [1] Kicman AT. (2008). British Journal of Pharmacology. PMID: 18500378. [2] Hartgens F, Kuipers H. (2004). Sports Medicine. PMID: 15248788. [3] Schänzer W. (1996). Clinical Chemistry. PMID: 8855153. For research use only. Not for human or veterinary use.